Pfizer
Wyeth acquisition boosts Pfizer results
August 4, 2010Sales and Marketing 2010 financials, Pfizer, Q2
Pfizer’s second quarter results received a huge boost from the company’s multi-billion dollar acquisition of Wyeth last October. Sales of …
JWT wins Pfizer account, denies it’s ‘Viagra 2’
July 30, 2010Medical Communications JWT, Pfizer, viagra
UK advertising agency JWT London has won an account from Pfizer, but played down media reports it had been appointed …
Digital Pharma: UK health clinic first for Pfizer
July 28, 2010Medical Communications Digital Pharma blog, Pfizer, digital patients, digital pharma med coms, disease awareness campaigns, sexual health
Men in the UK can now go online for confidential advice and information about any health problem through a unique …
Digital Pharma: Pfizer puts mental health diagnosis tools online
July 26, 2010Medical Communications Digital Pharma blog, Pfizer, depression, digital patients
Pfizer has put two widely used mental health assessment tools online for the public to use. It aims to improve …
Pfizer forced to halt pain drug trials
July 20, 2010Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
Pfizer plant ready to milk Asian infant formula market
July 9, 2010Manufacturing and Production Pfizer, Singapore, manufacturing, nutrition
Pfizer has spent $100 million to double the size of a manufacturing facility in Singapore to help it boost its …
Digital Pharma: First pharma iPad apps
June 25, 2010Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone
The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …
Pfizer plant cleared by FDA to make NicOx drug
June 24, 2010Manufacturing and Production Capsugel, NicOx, Pfizer, manufacturing, naproxcinod
Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …
Pfizer withdraws blood cancer drug in US
June 22, 2010Sales and Marketing AML, Mylotarg, Pfizer, blood cancer
The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …
Digital Pharma: Byte-sized roundup
June 18, 2010Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media
This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
Pfizer forms rare diseases unit
June 15, 2010Research and Development Orphan, Pfizer
Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …
Pfizer appoints neuroscience research head
June 10, 2010Research and Development Pfizer, appointment, research and development
Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …
‘Stellar’ performance from targeted lung cancer drug
June 9, 2010Research and Development Pfizer, biomarkers, crizotinib
A new targeted treatment for non small cell lung cancer has produced spectacular results in a sub-group of patients. Pfizer’s …
Pfizer launches UK pharmacy service
June 7, 2010NHS, NHS Constitution, NHS Health Check, Pfizer
Pfizer has launched a new pharmacy-based service that will enable Primary Care Trusts in England to provide the NHS Health …
Pfizer recalls Indian-made intravenous drugs
June 7, 2010Manufacturing and Production Claris Lifesciences, Pfizer, manufacturing compliance, recalls
Pfizer is recalling two intravenous antibiotics and an anti-nausea medication after particulate matter was found to be floating in them, leading …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
